ArticleInflammopharmacology2025

Potential repurposing of lapatinib and pazopanib as neuroprotective agents in a rat model of Huntington's disease.

Nada Ezeldine-Elmahalawy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.